http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102232936-B
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7c0a5a3e19633705b74da621161347d5 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-216 |
| filingDate | 2010-04-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2014-06-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_43df2a4cba4ed327c444c10652100566 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_54cda06fc22ef42a45c08181b566db48 |
| publicationDate | 2014-06-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-102232936-B |
| titleOfInvention | Prescription and application of capsule for reducing hyperlipidemia model cholesterol |
| abstract | The invention discloses a prescription and an application of a capsule for reducing hyperlipidemia model cholesterol. The capsule of the invention is a capsule containing a new phenoxy aromatic acid compound methyoxylphenylpropionic acid p-chlorophenoxyisobutyrate, and each capsule can contain 0.125 g or 0.25 g of methyoxylphenylpropionic acid p-chlorophenoxyisobutyrate. A preparation method of the capsule in the invention comprises the following steps: uniformly mixing a prescription bulk drug methyoxylphenylpropionic acid p-chlorophenoxyisobutyrate with accessories (except magnesium stearate); putting into a crusher to fully mill to allow powder to pass through a screen mesh with more than 80 meshes; preparing a soft material through mixing with an ethanol solution with a certain dissolvability as a wetting agent; preparing uniformly stirred soft material into particles; placing into a circulatory air dry oven with a temperature of 60 to 80 DEG C to dry; adding the well dried particles to magnesium stearate and uniformly mixing; granulating; examining intermediates; loading into the capsule; and packaging. So the capsule is finished. The capsule for reducing hyperlipidemia model cholesterol of the present invention can generate the effect of anti-hyperlipidemia. |
| priorityDate | 2010-04-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 49.